Search Results - "Id Said, Badr"

Refine Results
  1. 1

    Outcomes for oligometastatic head and neck cancer treated with stereotactic body radiotherapy: Results from an international multi‐institutional consortium by Id Said, Badr, Mutsaers, Adam, Chen, Hanbo, Husain, Zain A., Biswas, Tithi, Dagan, Roi, Erler, Darby, Foote, Matthew, Louie, Alexander V., Redmond, Kristin, Ricardi, Umberto, Sahgal, Arjun, Poon, Ian

    Published in Head & neck (01-10-2023)
    “…Abstract Background We report the results of an international multi‐institutional cohort of oligometastatic (OMD) head and neck cancer (HNC) patients treated…”
    Get full text
    Journal Article
  2. 2

    Demographics, pattern of practice and clinical outcomes in rectal squamous cell carcinoma by Id Said, Badr, Buchan, David, Liu, Zijin, Kim, John, Hosni, Ali, Brierley, James D., Chadi, Sami, Grant, Robert C., Kalimuthu, Sangeetha, Liu, Zhihui Amy, Lukovic, Jelena

    Published in Colorectal disease (01-04-2023)
    “…Aim The aim of this study was to describe the baseline clinical features, treatment patterns and outcomes in rectal squamous cell carcinoma (SCC). Method This…”
    Get full text
    Journal Article
  3. 3

    Stereotactic Body Radiotherapy for Extracranial Oligometastatic Disease from Head and Neck Primary Cancers: A Systematic Review and Meta-Analysis by Mutsaers, Adam, Akingbade, Aquila, Louie, Alexander V, Id Said, Badr, Zhang, Liying, Poon, Ian, Smoragiewicz, Martin, Eskander, Antoine, Karam, Irene

    Published in Cancers (20-02-2024)
    “…Stereotactic body radiotherapy (SBRT) is increasingly used to treat disease in the oligometastatic (OM) setting due to mounting evidence demonstrating its…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Treatment Patterns and Outcomes of Women with Symptomatic and Asymptomatic Breast Cancer Brain Metastases: A Single‐Center Retrospective Study by Gao, Yizhuo Kelly, Kuksis, Markus, Id Said, Badr, Chehade, Rania, Kiss, Alex, Tran, William, Sickandar, Faisal, Sahgal, Arjun, Warner, Ellen, Soliman, Hany, Jerzak, Katarzyna J.

    Published in The oncologist (Dayton, Ohio) (01-11-2021)
    “…Background Breast cancer is the most common cancer among women worldwide and the second leading cause of brain metastases (BrM). We assessed the treatment…”
    Get full text
    Journal Article
  6. 6

    Trastuzumab emtansine increases the risk of stereotactic radiosurgery-induced radionecrosis in HER2 + breast cancer by Id Said, Badr, Chen, Hanbo, Jerzak, Katarzyna J., Warner, Ellen, Myrehaug, Sten, Tseng, Chia-Lin, Detsky, Jay, Husain, Zain, Sahgal, Arjun, Soliman, Hany

    Published in Journal of neuro-oncology (01-08-2022)
    “…Introduction In this study, we investigate factors associated with radionecrosis (RN) in HER2 + (human epidermal growth factor receptor 2) patients with brain…”
    Get full text
    Journal Article
  7. 7

    Patterns of treatment and outcomes of patients with brain-only metastatic breast cancer by Id Said, Badr, Soliman, Hany, Moravan, Veronika, Myrehaug, Sten, Tseng, Chia-Lin, Detsky, Jay, Sahgal, Arjun, Warner, Ellen, Jerzak, Katarzyna J.

    Published in Journal of neuro-oncology (01-09-2023)
    “…Background We characterized the risk factors and survival of metastatic breast cancer (MBC) patients with brain metastases (BrM) as the first and only site of…”
    Get full text
    Journal Article
  8. 8

    A functional variant in miR-605 modifies the age of onset in Li-Fraumeni syndrome by Id Said, Badr, Malkin, David

    Published in Cancer genetics (01-01-2015)
    “…Li-Fraumeni syndrome (LFS) is a rare cancer predisposition syndrome, typically associated with germline mutations in the TP53  gene. Despite the high…”
    Get full text
    Journal Article
  9. 9

    Super-Transactivation TP53 Variant in the Germline of a Family with Li-Fraumeni Syndrome by Id Said, Badr, Kim, Han, Tran, James, Novokmet, Ana, Malkin, David

    Published in Human mutation (01-09-2016)
    “…ABSTRACT Li–Fraumeni Syndrome (LFS) is a rare autosomal dominant familial cancer syndrome, characterized by multiple malignancies and frequent germline…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Transcriptome-wide characterization of the endogenous miR-34A-p53 tumor suppressor network by Samuel, Nardin, Wilson, Gavin, Id Said, Badr, Pan, Anna, Deblois, Genevieve, Fischer, Nicholas W, Alexandrova, Roumiana, Casallo, Guillermo, Paton, Tara, Lupien, Mathieu, Gariepy, Jean, Merico, Daniele, Hudson, Thomas J, Malkin, David

    Published in Oncotarget (02-08-2016)
    “…microRNA-34A is a critical component of the p53 network and expression of miR- 34A is down-regulated by promoter hypermethylation or focal deletions in…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Predictors of brain metastases in patients with oligometastatic solid tumours treated with stereotactic body radiation therapy by Fan, Kevin Yijun, Jerzak, Katarzyna Joanna, Kumar, Sudhir, Moravan, Veronika, Id Said, Badr, Das, Sunit, Louie, Alexander V, Soliman, Hany, Sahgal, Arjun, Chen, Hanbo

    Published in Journal of neuro-oncology (04-10-2024)
    “…In patients with oligometastatic disease (OMD) treated with stereotactic body radiation therapy (SBRT), those who develop brain metastases (BrM) may have poor…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20